Endocrine Society Merges with APDEM 

Fresh off of a successful ENDO 2024 in Boston in June, the Endocrine Society announced it is merging with the Association of Program Directors in Endocrinology, Diabetes, and Metabolism (APDEM). 
 
The APDEM represents the academic leaders of more than 135 training programs that prepare fellows for clinical and research careers in endocrinology and metabolism.  
 
“The Endocrine Society and APDEM share a commitment to investing in and nurturing the endocrinology workforce,” says Endocrine Society President John Newell-Price, MD, PhD, FRCP. “Together, we offer a unified voice to support and advocate for clinical practitioners, endocrine researchers, and trainees through all stages of their careers. We are grateful to the Endocrine Society’s Past-President Stephen Hammes, MD, PhD, and APDEM Past-President Odelia Cooper, MD, for their leadership and strategic vision in overseeing the merger.” 
 
For more than 25 years, the organizations have partnered together to serve the APDEM’s community of endocrine program directors and the next generation of endocrinologists. The Endocrine Society has functioned as the APDEM’s association manager since 1998.  

While at ENDO 2024, there was a reception for members of APDEM. Pictures are (l to r): APDEM Council President Matthew J. Levine, MD; APDEM Immediate Past-President Odelia Cooper, MD; Endocrine Society Immediate Past-President Stephen R. Hammes, MD, PhD, and Endocrine Society President John Newell-Price, MD, PhD, FRCP.

The next stage of the evolving relationship will allow the combined organization to increase efficiencies and fulfill a shared commitment to supporting the endocrinology workforce. The APDEM will maintain its independent identity, governing council, and committee structure as a division of the Endocrine Society. 
 
“By strengthening our relationship, we will be able to connect with larger audiences and strengthen the pipeline of people entering the endocrine field,” says APDEM Council President Matthew J. Levine, MD. “As a unified organization, we look forward being able to achieve far more than we could before.”  
 
The organizations have a strong record of working together on important issues impacting education and preparation of the future workforce. This merger represents a continuation of that preexisting relationship.  

“The endocrine field is facing a workforce shortage needed to treat the rapidly growing population with endocrine conditions such as diabetes, obesity, thyroid conditions, and osteoporosis. For our field to thrive, the larger endocrine community needs to unite to address these issues and to recruit more of our students and trainees to become our colleagues.” 

John Newell-Price, MD, PhD, FRCP, President, Endocrine Society

“As we implement operational changes over the coming months to effectively integrate APDEM into the Endocrine Society, the changes will enhance our members’ experience,” Levine says.  
 
The Endocrine Society and the APDEM’s new relationship will be aligned with similar organizations serving other medical subspecialties. Eighteen of the 20 American Board of Internal Medicine’s (ABIM) subspecialty parent organizations directly manage their corresponding fellowship programs. 
 
“The advancement of our partnership comes at a crucial time,” Newell-Price says. “The endocrine field is facing a workforce shortage needed to treat the rapidly growing population with endocrine conditions such as diabetes, obesity, thyroid conditions, and osteoporosis. For our field to thrive, the larger endocrine community needs to unite to address these issues and to recruit more of our students and trainees to become our colleagues.” 

The APDEM Reception at ENDO 2024 in Boston was a chance for the members of the organization to celebrate the year’s successes while also finding time to socialize on the EXPO floor while everyone convened for the largest endocrinology conference in the world.

You may also like

  • Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

    Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:…

  • Bianco Named Vice President and Vice Provost for Research, Chief Research Officer at UTMB

    Antonio Bianco, MD, PhD, has joined the University of Texas Medical Branch (UTMB) as vice president and vice provost, research, and chief research officer, effective Sept. 1. A renowned physician-scientist, scholar, and research leader, Bianco possesses an impressive academic career that includes influential contributions to the field of thyroid diseases and an enduring commitment to…

Find more in